FierceBiotech

AcelRx Announces Primary Endpoint Met in Phase 3 Non-Inferiority Study of Sublingual Sufentanil NanoTab PCA System vs. IV PCA Morphine for Post-Operative Pain

AcelRx Announces Primary Endpoint Met in Phase 3 Non-Inferiority Study of Sublingual Sufentanil NanoTab PCA System vs. IV PCA Morphine for Post-Operative Pain -In this open-label study, the Sufentanil ...
TechRepublic

System Center isn’t going away, but Microsoft Endpoint Manager will make office PCs faster

System Center isn’t going away, but Microsoft Endpoint Manager will make office PCs faster Your email has been sent A new name should make Microsoft's strategy for managing PCs through Config Manager ...
https//fedtechmagazine.com

Improving Endpoint Security in the New Normal

Evan Doty is a senior field solution architect at CDW focused on hybrid cloud and Microsoft Azure. His areas of expertise include LAN and WAN network design and implementation, Windows system ...
FiercePharma

AcelRx Announces Primary Endpoint Met in Phase 3 Non-Inferiority Study of Sublingual Sufentanil NanoTab® PCA System vs. IV PCA Morphine for Post-Operative Pain

AcelRx Announces Primary Endpoint Met in Phase 3 Non-Inferiority Study of Sublingual Sufentanil NanoTab® PCA System vs. IV PCA Morphine for Post-Operative Pain -In this open-label study, the ...